BENEDETTI PANICI, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 31.811
EU - Europa 9.637
AS - Asia 5.866
SA - Sud America 317
AF - Africa 264
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 8
Totale 47.981
Nazione #
US - Stati Uniti d'America 31.431
IT - Italia 3.262
SG - Singapore 2.258
IN - India 1.657
CN - Cina 1.496
SE - Svezia 1.300
DE - Germania 1.003
FI - Finlandia 916
UA - Ucraina 875
RU - Federazione Russa 800
CA - Canada 289
GB - Regno Unito 288
IE - Irlanda 222
TG - Togo 168
BR - Brasile 163
BG - Bulgaria 159
AT - Austria 122
RO - Romania 107
AR - Argentina 106
FR - Francia 100
NL - Olanda 97
BE - Belgio 96
MX - Messico 82
ID - Indonesia 75
CH - Svizzera 65
AU - Australia 63
TR - Turchia 60
GR - Grecia 55
ES - Italia 48
TW - Taiwan 41
IR - Iran 40
ZA - Sudafrica 33
JP - Giappone 31
PH - Filippine 23
EG - Egitto 22
KR - Corea 21
IL - Israele 20
PL - Polonia 20
HU - Ungheria 19
PK - Pakistan 19
HK - Hong Kong 18
CO - Colombia 15
LT - Lituania 15
MY - Malesia 15
NZ - Nuova Zelanda 15
CL - Cile 14
AE - Emirati Arabi Uniti 11
KZ - Kazakistan 11
PT - Portogallo 11
SC - Seychelles 11
IQ - Iraq 10
PE - Perù 10
LK - Sri Lanka 8
MA - Marocco 8
RS - Serbia 8
DK - Danimarca 7
LV - Lettonia 7
VN - Vietnam 7
CZ - Repubblica Ceca 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
BD - Bangladesh 5
HR - Croazia 5
MK - Macedonia 5
TH - Thailandia 5
UZ - Uzbekistan 5
EC - Ecuador 4
EE - Estonia 4
EU - Europa 4
LU - Lussemburgo 4
NG - Nigeria 4
TN - Tunisia 4
JM - Giamaica 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BJ - Benin 2
CI - Costa d'Avorio 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
MV - Maldive 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
TJ - Tagikistan 2
VE - Venezuela 2
YE - Yemen 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
Totale 47.971
Città #
Fairfield 5.665
Woodbridge 2.585
Ashburn 2.532
Seattle 2.058
Houston 2.033
Chandler 2.002
Wilmington 1.744
Cambridge 1.722
Singapore 1.572
Ann Arbor 1.197
Beijing 1.173
Rome 1.146
Princeton 1.115
Plano 736
San Paolo di Civitate 606
Santa Clara 564
Millbury 500
Lawrence 455
San Diego 412
Boston 383
Dearborn 310
Jacksonville 291
Helsinki 257
Andover 236
Des Moines 204
Dublin 186
Moscow 186
Bremen 173
Lomé 168
Sofia 155
Norwalk 151
Toronto 151
New York 101
Federal 100
Brussels 92
Vienna 92
Falls Church 83
Milan 83
Falkenstein 73
Jakarta 73
Boardman 69
San Mateo 68
Mannheim 66
Ottawa 59
Los Angeles 57
Bühl 56
Redwood City 50
Yubileyny 50
Stockholm 44
Istanbul 41
Hefei 38
Fremont 37
Mexico City 35
London 33
Regensburg 32
North York 31
Florence 30
Kunming 29
Nanjing 29
Nuremberg 27
Pune 23
Galway 22
Phoenix 22
Sydney 22
Munich 21
Tokyo 21
Turin 21
Chicago 20
Dallas 20
Bologna 19
Bern 18
Frankfurt am Main 18
Redmond 18
Berlin 17
Naples 17
Angeles City 16
Guangzhou 16
Southend 16
Buffalo 15
Jinan 15
Amsterdam 14
Auburn Hills 14
Muizenberg 14
Cairo 13
Las Vegas 13
São Paulo 13
Hyderabad 12
Indiana 12
Manchester 12
Mumbai 12
Paris 12
San Francisco 12
Hamilton 11
Hebei 11
Kaohsiung City 11
Parma 11
Torino 11
Birmingham 10
Catania 10
Dubai 10
Totale 34.861
Nome #
D-mannose: a promising support for acute urinary tract infections in women. A pilot study 808
L’intervento secondo Lahodny 242
Maternal and perinatal outcomes of pregnant women with SARS-COV-2 infection 233
Colporrafia anteriore più TVT-O per il trattamento dell’incontinenza urinaria da sforzo associata a cistocele: uno studio pilota. 194
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis 153
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection 146
The Efficacy of Fractional {CO}2 Laser in the Treatment of Genitourinary Syndrome of Menopause. A Large Prospective Observational Study 145
A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells. 142
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 137
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 135
Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases 131
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer 126
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 125
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 122
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial 120
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY IN PATIENTS AFFECTED BY VAGINAL CARCINOMA 116
Antiphospholipid syndrome: an update on risk factors for pregnancy outcome 115
Quality of life and sexual function after type C2/type III radical hysterectomy for locally advanced cervical cancer: a prospective study. 115
Functions and the emerging role of the foetal liver into regenerative medicine 114
Fertility preservation in gynaecologic cancers 112
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 112
Endometrioma-associated infertility: is surgery still the best way to go? 111
Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability 110
Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: A randomized controlled trial 110
Recurrent Buschke-Löwenstein Tumor Treated Using CO2 Laser Vaporization 110
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers 109
Brain metastases from malignant Brenner tumor of the ovary. a case report and a literature review 109
Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain 108
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 108
Management of hydrosalpinx before IVF: A literature review. 107
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials 105
Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients 105
Characterization of Human Vaginal Mucosa Cells for Autologous In Vitro Cultured Vaginal Tissue Transplantation in Patients with MRKH Syndrome. 105
Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients 104
Bevacizumab in ovarian cancer: state of the art and unanswered questions 103
Re: Axelsen SM, Bek KM, Petersen LK. 2007. Urodynamic and ultrasound characteristics of incontinence after radical hysterectomy. Neurourol urodynam 102
Sonohysterosalpingography: Comparison of foam and saline solution 102
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis 102
Is low maximal urethral closure pressure alone a determinant for failure after transobturator midurethral sling placement? 101
A multicentre collaborative study on the use of cold scalpel and electrocautery for midline abdominal incision 100
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know 100
Postpartum Posterior Reversible Encephalopathy Syndrome (PRES): Three Case Reports and Literature Review 99
Pelvic lymphadenectomy for cervical carcinoma: Laparotomy extraperitoneal, transperitoneal or laparoscopic approach? A randomized study 98
Alpha lipoic acid in obstetrics and gynecology 98
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. 97
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 97
Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome. outcome after 6 months of treatment with ospemifene 97
null 96
A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life 96
Inpatient vs outpatient management and timing of delivery of uncomplicated monochorionic monoamniotic twin pregnancy: the MONOMONO study 96
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review 96
Immune check-point in cervical cancer 95
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells 94
Fertility preservation in ovarian tumours 94
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. 94
Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women 94
A retrospective study on advanced maternal age and assisted reproductive techniques, medico-legal advice, "food for thought" 94
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 94
Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386) 93
Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review 93
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 92
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women 92
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells. a potential role in platinum resistance 92
Neoadjuvant Chemotherapy Plus Fertility-Sparing Surgery in Locally Advanced Cervical Cancer: Case Report 92
Laparotomic myomectomy in the 16th week of pregnancy: a case report. 91
Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes. A meta-analysis 91
Update in non invasive prenatal testing 91
HPV-related vulvar diseases and perspectives of p16INK4a immunochemistry: a review of the literature 91
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis 90
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 90
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis 90
Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta 89
Continuous versus cyclic oral contraceptives for endometriosis: any conclusive evidence? 89
PARP inhibition: a promising therapeutic target in ovarian cancer 89
Treatment of the Mayer-Rokitansky-Küster-Hauser syndrome with autologous in vitro cultured vaginal tissue. descriptive study of long-term results and patient outcomes 89
Past, present and future strategies of immunotherapy in gynecological malignancies 88
Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer 88
null 88
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 88
Ixabepilone for the treatment of endometrial cancer 88
Unexpected Metastasis of High Grade Serous Ovarian Cancer to Breast: Case Report and Literature Review 88
Distal phalange necrosis: A severe manifestation of palmar plantar erythrodysesthesia 87
Immune effects of trastuzumab. 87
Beyond circulating microRNA biomarkers. urinary microRNAs in ovarian and breast cancer 87
Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts 87
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients - A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD) 87
GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study 86
Mechanical bowel preparation before gynecologic laparoscopy: a randomized, single-blind, controlled trial 86
New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection 86
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: technique and feasibility. 85
Solitary gastric recurrence from ovarian carcinoma: A case report and literature review 85
Cancer testis antigen expression in primary and recurrent vulvar cancer: Association with prognostic factors 85
Is there a real standard for stage IVa cervical cancer? 85
Vulvar malignancy in neurofibromatosis syndrome 85
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. 85
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan. 85
Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques 85
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer 85
Environmental contaminants exposure and preterm birth: a systematic review 85
Massive haemoperitoneum caused by uterine leiomyoma: a case report 85
Totale 11.083
Categoria #
all - tutte 147.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.011 0 0 0 0 0 0 0 1.313 1.267 1.355 745 331
2020/20213.869 424 499 213 356 168 189 145 364 370 457 452 232
2021/20228.362 84 420 801 301 1.121 298 164 915 653 656 1.116 1.833
2022/20238.347 1.967 1.690 376 857 803 822 173 424 692 104 292 147
2023/20244.289 310 527 185 387 394 427 146 442 41 551 373 506
2024/20254.479 409 635 589 344 823 633 927 119 0 0 0 0
Totale 49.994